Literature DB >> 7927349

Characterization of several DNA polymorphic markers in the LIF gene region.

A Moreau-Aubry1, M T Andre, M C Devilder, F Resche, O Delattre, G Thomas, J P Moisan.   

Abstract

We describe seven restriction fragment length polymorphisms (RFLPs) in the Leukemia Inhibitory Factor (LIF) gene region. These new markers, found using a cosmid contig, have been used to map precisely the chromosome 22 long arm.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7927349     DOI： 10.1007/bf00201613

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  11 in total

1.  Isolation and mapping of 62 new RFLP markers on human chromosome 11.

Authors:  T Tokino; E Takahashi; M Mori; A Tanigami; T Glaser; J W Park; C Jones; T Hori; Y Nakamura
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

2.  Isolation and mapping of a polymorphic DNA sequence (pEFZ31) on chromosome 22 [D22S32].

Authors:  K Krapcho; Y Nakamura; E Fujimoto; R Eldridge; M Leppert; P O'Connell; G M Lathrop; J M Lalouel; R White
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

3.  Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q.

Authors:  M Budarf; B S Emanuel; T Mohandas; D V Goeddel; D G Lowe
Journal:  Cytogenet Cell Genet       Date:  1989

4.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

5.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

Review 6.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells.

Authors:  J F Moreau; D D Donaldson; F Bennett; J Witek-Giannotti; S C Clark; G G Wong
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

8.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

Authors:  G A Rouleau; P Merel; M Lutchman; M Sanson; J Zucman; C Marineau; K Hoang-Xuan; S Demczuk; C Desmaze; B Plougastel
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

9.  Neurofibromatosis type 2 appears to be a genetically homogeneous disease.

Authors:  S A Narod; D M Parry; J Parboosingh; G M Lenoir; M Ruttledge; G Fischer; R Eldridge; R L Martuza; M Frontali; J Haines
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

10.  Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF).

Authors:  D P Gearing; N M Gough; J A King; D J Hilton; N A Nicola; R J Simpson; E C Nice; A Kelso; D Metcalf
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.